Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial
This study has been terminated.
( Sufficient evidence of efficacy not met. Discontinuation not based on any safety concerns. )
Study NCT00675025
Information provided by Eisai Inc.
First Received on May 7, 2008.
Last Updated on December 10, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
